© 2019 by Sciencia Consulting, Inc. All Rights Reserved. US Government Certified Women Owned Small Business. 

  • LinkedIn Social Icon
  • Twitter Social Icon
Search
  • Sciencia Consulting

Tumor Immunology Weekly News, January 20, 2020

Updated: Feb 1


Funding Opportunities


Submissions open Jan 21 for SITC 2020 Fellowships, including the SITC-Genentech Women in Cancer Immunotherapy Fellowship.





Scientific Discoveries


Scientists at Boston University develop mesenchyme-free intestinal organoids from human iPSCs.


Image from CReM.



Intestine-chip populated with organoids performs better than organoids alone in preclinical testing.


Image by Emulate Inc.





Osteopontin-responsive Lgr5-CD44+ cells could be new targets for gastroesophageal cancer, according to Cornell study.


Image by the Nitikin Lab sourced from Cornell News.





New Science article showed selective ablation of PD-1 in myeloid cells was just as effective at limiting tumor growth as global deletion of PD-1.


Image sourced from Wikipedia.






New Organoid Research Facilities


WFORCE is a new organoid research center at the Wake Forest School of Medicine - focusing on personalized medicine, rare tumors and adaptive immunity.



Check back here for more news next week or follow us on Twitter or LinkedIn.

6 views